Target intelligence / Profile preview

Small mitochondrial ribosomal subunit (mt-SSU)

Target
mt-SSU
Molecular classification
Other (ribosomal complex), Riboprotein complex, Structural protein-RNA complex
01

Overview

The small mitochondrial ribosomal subunit (mt-SSU) is the smaller component of the mitochondrial ribosome (mitoribosome), responsible for initiating and decoding mitochondrial mRNA translation encoded by mitochondrial DNA[3][1][2][4][5]. In mammals, the small subunit is designated as the 28S subunit, containing a minimized 12S rRNA and multiple nuclear-encoded mitoribosomal proteins (MRPs) with unique extensions to adapt to the mitochondrial environment[1][3]. The mt-SSU works together with the large subunit (mt-LSU, 39S in mammals) to synthesize 13 core protein components of the electron transport chain essential for oxidative phosphorylation[3][1]. Defects in mt-SSU assembly or function are associated with a variety of human diseases, especially those impacting energy-demanding tissues like heart, muscle, and brain, including Leigh syndrome, deafness, and some forms of cardiomyopathy[3]. Notes on is_incorrect: "Small mitochondrial ribosome" is not a canonical molecular target name and is ambiguous because the active complex is called the mitochondrial ribosome (mitoribosome), which has defined large (mt-LSU) and small (mt-SSU) subunits; "small mitochondrial ribosome" should instead be referred to as "small mitochondrial ribosomal subunit" (mt-SSU)[3][1]. It is not a receptor, enzyme, transporter, or classic drug target, but is a central component of mitochondrial biology and dysfunction can be pathogenic. There are currently no drugs directly targeting the mt-SSU in clinical medicine, though some antibiotics and small molecules can cause mitochondrial ribosomal dysfunction as off-target effects[3].

Other names
mitochondrial small ribosomal subunitmitoribosomal small subunit28S mitoribosomal subunit (mammalian)mt-SSU
02

Biological functions

Protein synthesisOxidative phosphorylationTranslation of mitochondrial mRNAsATP production
03

Disease associations

Neurodegenerative diseaseCardiomyopathyLeigh syndromeDeafnessOther mitochondrial diseases
04

Safety considerations

Potential mitochondrial toxicity if impairedmulti-organ defects due to loss of mitochondrial translation

Beyond the preview

Go deeper on Small mitochondrial ribosomal subunit (mt-SSU).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small mitochondrial ribosomal subunit (mt-SSU).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call